Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome
Initiation of REVEAL pediatric trial in the U.S.broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old with stage three Ret...
United Kingdom United States University Medical Center Elizabeth Berry Kravis Sukumar Nagendran Carolyn Hawley
Source: businessinsider.com